An APGI Award sponsored by Sanofi
The Maurice-Marie Janot Award recognizes an individual researcher (also in the context of a research team), who published original and innovative research articles in the fields of Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.
Jury and selection procedure
The Jury is composed of 70 scientists from all over the world, who are known for their relevant contributions to the Pharmaceutical Sciences.
In a first round, each jury member nominates three individuals. This allows establishing a short list of five highest ranked candidates. In the second round, the laureate is selected by all jury members from this short list.
The Jury members base their nominations on the researchers’ publications and other contributions available in literature, in particular considering their originality, creativity and impact in the field. The laureate’s work can cover aspects from the basic sciences to applied pharmaceutical research, devoted to Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology. This includes for instance new drug delivery systems, dosage form manufacturing, strategies for bioavailability enhancement, process optimization & validation, process analytical technologies, new excipients, packaging and various other aspects.
No restrictions are made with respect to nationality, origin (industry, academia or regulatory) or specialization (pharmacy, chemical engineering or other fields) of the nominee.
The laureate is announced during the APGI Award Ceremony at the World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.
The Maurice-Marie Janot award is kindly sponsored by Sanofi.
2020 Maurice Marie-Janot Award Laureate: Robert Langer
Professor Robert Langer at the Massachusetts Institute of Technology receives the “2020 Maurice Marie-Janot Award”. This price recognizes an individual researcher, whose pioneering work has a groundbreaking impact in the fields of Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology. The Jury is composed of 70 scientists from all over the world, who are known for their relevant contributions to the Pharmaceutical Sciences.
Robert Langer is one of 12 Institute Professors at the Massachusetts Institute of Technology (MIT); being an Institute Professor is the highest honor that can be awarded to a faculty member. He has written nearly 1,500 articles, which have been cited over 300,000 times; his h-index of 272 is the highest of any engineer in history. He has more than 1,350 issued and pending patents worldwide. His patents have been licensed or sublicensed to over 400 companies. He served as Chairman of the FDA’s Science Board (its highest advisory board) from 1999-2002. His over 220 awards include both the United States National Medal of Science and the United States National Medal of Technology and Innovation (he is one of 4 living individuals to have received both these honors), the Charles Stark Draper Prize (often called the Engineering Nobel Prize), Albany Medical Center Prize, Breakthrough Prize in Life Sciences, Kyoto Prize, Wolf Prize for Chemistry, Millennium Technology Prize, Priestley Medal (highest award of the American Chemical Society), Gairdner Prize, Dreyfus Prize in Chemical Sciences, Maurice Marie-Janot Award, and the Lemelson-MIT prize, for being “one of history’s most prolific inventors in medicine.” He holds 34 honorary doctorates and has been elected to the National Academy of Medicine, the National Academy of Engineering, the National Academy of Sciences and the National Academy of Inventors.
2018 Maurice Marie-Janot Award Laureate: Elias Fattal
Elias Fattal, is a full professor in Pharmaceutical Technology at the University of Paris-Sud in Châtenay-Malabry in France and has been President of APGI from 2003 to 2010. He received his Pharmacy Degree and Ph.D. in Pharmaceutical Sciences from the University of Paris-Sud and followed a three year residency in hospital pharmacy at the University of Lille. After visiting the Department of Pharmaceutical Chemistry at the University of California, San Francisco for a post-doctoral position, he joined in 1992, the University of Paris-Sud as associate Professor and was appointed full Professor in 2000. He is heading the Institut Galien Paris-Sud a research unit associated to the CNRS. Dr Fattal research focuses on the design of nanotechnologies for targeted or local delivery of drugs and nucleic acids. He has authored more than 235 peer-reviewed articles and 28 book chapters and has issued 13 international patents (most of them granted in different countries). He has received the Pharmaceutical Sciences World Congress Research Achievement (2007), the controlled Release Society fellow Award (2016) and was awarded in 2016 by the French Academy of Sciences. He serves in the editorial board of 8 scientific journals.